Pacira BioSciences Inc (PCRX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
David M. Stack
Employees:
518
5 SYLVAN WAY, SUITE 300, PARSIPPANY, NJ 07054
973-254-3560

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company. It develops, commercializes, and manufactures pharmaceutical products for use in hospitals and ambulatory surgery centers. It develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. The company markets EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic, indicated for administration into the surgical site to produce postsurgical analgesia; and DepoCyt(e), a liposomal formulation of the chemotherapeutic agent cytarabine indicated for the intrathecal treatment of lymphomatous meningitis, a cancer of the immune system. Its product pipeline comprise EXPAREL that has completed Phase II clinical trials for postsurgical analgesia-nerve block administration; DepoNSAID, which is in preclinical trials for the relief of that is in preclinical trials acute pain; and DepoTXA is currently in pre-clinical development, which is used to treat or prevent excessive blood loss during surgery by promoting hemostasis. Pacira Pharmaceuticals was founded in December 2006 and is headquartered in Parsippany, NJ.

Data derived from most recent annual or quarterly report
Market Cap 2.352 Billion Shares Outstanding44.455 Million Avg 30-day Volume 619.592 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 80.0 / 45.05 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from PCRX instead.

View recent insider trading info

Funds Holding PCRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PCRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WINSTON ROY CHIEF MEDICAL OFFICER

  • Officer
46,456 2021-08-03 5

SLONIN JONATHAN CHIEF CLINICAL OFFICER

  • Officer
36,350 2021-08-03 2

RIKER LAUREN BULLARO VICE PRESIDENT, FINANCE

  • Officer
49,994 2021-07-28 5

REINHARDT MAX PRESIDENT, REST OF WORLD

  • Officer
17,500 2021-07-02 5

STACK DAVID M CEO AND CHAIRMAN

  • Officer
  • Director
328,540 2021-06-09 4

LONGENECKER JOHN P PHD

  • Director
26,449 2021-06-09 2

WILLIAMS KRISTEN MARIE CHIEF ADMINISTRATIVE OFFICER

  • Officer
67,725 2021-06-09 3

HASTINGS PAUL J

  • Director
14,178 2021-06-09 3

BREGE LAURA

  • Director
16,613 2021-06-09 2

GREENSTREET YVONNE

  • Director
19,713 2021-06-09 1

REINHART CHARLES A. III CHIEF FINANCIAL OFFICER

  • Officer
45,799 2021-06-09 2

LARANJEIRA CHARLES ANTHONY CHIEF TECHNICAL OFFICER

  • Officer
43,181 2021-06-09 2

KRONENFELD MARK A.

  • Director
24,363 2021-06-09 1

FROIMSON MARK

  • Director
13,934 2021-06-09 2

MCLOUGHLIN DENNIS CHIEF CUSTOMER OFFICER

  • Officer
48,541 2021-06-09 2

MANNING DONALD C. CHIEF MEDICAL OFFICER

  • Officer
44,520 2021-06-09 3

CHRISTIE CHRISTOPHER

  • Director
9,952 2021-06-09 1

PACE GARY W

  • Director
137,156 2021-05-13 1

WICKI ANDREAS

  • Director
451,324 2021-03-12 2

SCRANTON RICHARD CHIEF SCIENTIFIC OFFICER

  • Officer
16,061 2019-11-08 0

WEILAND ROBERT J. CHIEF COMMERCIAL OFFICER

  • Officer
5,088 2018-06-04 0

BRAUNSTEIN SCOTT CHIEF OPERATING OFFICER

  • Officer
0 2018-01-03 0

JONES JAMES B SVP & CHIEF MEDICAL OFFICER

  • Officer
16,823 2017-11-20 0

WINGER DENNIS L

  • Director
7,490 2017-06-14 0

SCIBETTA JAMES S PRESIDENT

  • Officer
25,118 2017-06-05 0

MARKVICKA TAUNIA SVP, CHIEF COMMERCIAL OFFICER

  • Officer
8,809 2015-03-17 0

PATOU GARY CHIEF MEDICAL OFFICER

  • Officer
702 2014-08-07 0

MIDDLETON FRED A

  • Director
70,399 2013-06-21 0

EVNIN LUKE

  • Director
824,255 2013-06-12 0

PRATT JOHN GENERAL MANAGER, SAN DIEGO

  • Officer
No longer subject to file 2013-06-12 0

HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.

  • 10% Owner
No longer subject to file 2013-03-21 0

SANDERLING VENTURE PARTNERS VI LP

SANDERLING VI BETEILIGUNGS GMBH & CO KG

SANDERLING VENTURES MANAGEMENT VI

SANDERLING VI LIMITED PARTNERSHIP

SANDERLING VENTURE PARTNERS VI CO INVESTMENT FUND LP

MIDDLETON FRED A

  • Director
416,083 2013-03-15 0

SANDERLING VENTURE PARTNERS VI LP

SANDERLING VI BETEILIGUNGS GMBH & CO KG

SANDERLING VENTURES MANAGEMENT VI

SANDERLING VI LIMITED PARTNERSHIP

SANDERLING VENTURE PARTNERS VI CO INVESTMENT FUND LP

  • 10% Owner
866,083 2013-03-15 0

KAILIAN VAUGHN M

GADICKE ANSBERT

  • FORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2013-03-11 0

MPM BIOVENTURES IV QP LP

SCOPA JAMES PAUL

MPM BIOVENTURES IV GP LLC

MPM BIOVENTURES IV LLC

MPM ASSET MANAGEMENT INVESTORS BV4 LLC

MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG

FOLEY TODD

VANDER VORT JOHN

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2013-03-11 0

SANDERLING VENTURE PARTNERS VI LP

SANDERLING VI BETEILIGUNGS GMBH & CO KG

SANDERLING VI LIMITED PARTNERSHIP

SANDERLING VENTURE PARTNERS VI CO INVESTMENT FUND LP

MIDDLETON FRED A

  • Director
  • 10% Owner
602,286 2013-03-07 0

SANDERLING VENTURE PARTNERS VI LP

SANDERLING VI BETEILIGUNGS GMBH & CO KG

SANDERLING VI LIMITED PARTNERSHIP

SANDERLING VENTURE PARTNERS VI CO INVESTMENT FUND LP

  • 10% Owner
559,453 2013-03-07 0

SANDERLING VENTURE PARTNERS VI LP

SANDERLING VI BETEILIGUNGS GMBH & CO KG

SANDERLING VENTURES MANAGEMENT VI

SANDERLING VI LIMITED PARTNERSHIP

SANDERLING VENTURE PARTNERS IV CO INVESTMENT FUND LP

MIDDLETON FRED A

  • Director
  • 10% Owner
2,366,158 2013-01-24 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP III LLC

ISALY SAMUEL D

  • 10% Owner
No longer subject to file 2012-03-09 0

MPM BIOVENTURES IV QP LP

MPM BIOVENTURES IV GP LLC

MPM BIOVENTURES IV LLC

MPM ASSET MANAGEMENT INVESTORS BV4 LLC

MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG

FOLEY TODD

VANDER VORT JOHN

SCOPA JAMES PAUL

ST PETER STEVEN

  • 10% Owner
3,290,479 2011-11-21 0

MPM BIOVENTURES IV QP LP

MPM BIOVENTURES IV GP LLC

MPM BIOVENTURES IV LLC

MPM ASSET MANAGEMENT INVESTORS BV4 LLC

MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG

DOMBKOWSKI ASHLEY L

VANDER VORT JOHN

SCOPA JAMES PAUL

ST PETER STEVEN

GREENE WILLIAM

  • 10% Owner
2,828,941 2011-02-08 0

GORDON CARL L

  • Director
2,828,941 2011-02-08 0

LAMBERT WILLIAM SVP, PHARMACEUTICAL DEV

  • Officer
0 2011-02-02 0

WALTERS MARK SVP, TECHNICNICAL OPERATIONS

  • Officer
0 2011-02-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PACIRA BIOSCIENCES INC PCRX 2021-10-26 18:15:03 UTC -0.323 0.393 1700000
PACIRA BIOSCIENCES INC PCRX 2021-10-26 17:45:03 UTC -0.323 0.393 1700000
PACIRA BIOSCIENCES INC PCRX 2021-10-26 17:15:03 UTC -0.323 0.393 1700000
PACIRA BIOSCIENCES INC PCRX 2021-10-26 16:45:04 UTC -0.3598 0.4298 1700000
PACIRA BIOSCIENCES INC PCRX 2021-10-26 16:15:03 UTC -0.3598 0.4298 1700000
PACIRA BIOSCIENCES INC PCRX 2021-10-26 15:45:03 UTC -0.3598 0.4298 1700000
PACIRA BIOSCIENCES INC PCRX 2021-10-26 15:15:03 UTC -0.3598 0.4298 1700000
PACIRA BIOSCIENCES INC PCRX 2021-10-26 14:45:03 UTC -0.3598 0.4298 1700000
PACIRA BIOSCIENCES INC PCRX 2021-10-26 14:15:05 UTC -0.3598 0.4298 1700000
PACIRA BIOSCIENCES INC PCRX 2021-10-26 13:45:03 UTC -0.3598 0.4298 1700000
PACIRA BIOSCIENCES INC PCRX 2021-10-26 13:15:03 UTC -0.3598 0.4298 1700000
PACIRA BIOSCIENCES INC PCRX 2021-10-26 12:45:03 UTC -0.3598 0.4298 1700000
PACIRA BIOSCIENCES INC PCRX 2021-10-25 22:15:03 UTC -0.3598 0.4298 1100000
PACIRA BIOSCIENCES INC PCRX 2021-10-25 21:45:03 UTC -0.3598 0.4298 1100000
PACIRA BIOSCIENCES INC PCRX 2021-10-25 21:15:03 UTC -0.3598 0.4298 1100000
PACIRA BIOSCIENCES INC PCRX 2021-10-25 20:45:03 UTC -0.3598 0.4298 1100000
PACIRA BIOSCIENCES INC PCRX 2021-10-25 20:15:03 UTC -0.3598 0.4298 1100000
PACIRA BIOSCIENCES INC PCRX 2021-10-25 19:45:04 UTC -0.3598 0.4298 1100000
PACIRA BIOSCIENCES INC PCRX 2021-10-25 19:15:03 UTC -0.3598 0.4298 1100000
PACIRA BIOSCIENCES INC PCRX 2021-10-25 18:45:02 UTC -0.3598 0.4298 1100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
LoCorr Investment Trust- LoCorr Dynamic Equity Fund PCRX -403.0 shares, $-24454.04 2021-06-30 N-PORT
FORUM FUNDS- ABSOLUTE CONVERTIBLE ARBITRAGE FUND PCRX -35628.0 shares, $-2161907.04 2021-06-30 N-PORT
SEI INSTITUTIONAL MANAGED TRUST- SIMT Multi-Strategy Alternatives Fund PCRX -3955.0 shares, $-239989.4 2021-06-30 N-PORT
PACE SELECT ADVISORS TRUST- PACE Alternative Strategies Investments PCRX -2544.0 shares, $-149968.8 2021-07-31 N-PORT
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund PCRX -76483.0 shares, $-4508672.85 2021-07-31 N-PORT

Elevate your investments